CLOSED LOOP MEDICINE LTD

Active Altrincham

Research and experimental development on biotechnology

29 employees website.com
Healthcare and wellbeing Research and experimental development on biotechnology
C

CLOSED LOOP MEDICINE LTD

Research and experimental development on biotechnology

Founded 26 Jan 2017 Active Altrincham, England 29 employees website.com
Healthcare and wellbeing Research and experimental development on biotechnology

Previous Company Names

CLOSED LOOP PHARMA LTD 26 Jan 2017 — 6 Feb 2017
Accounts Submitted 26 Aug 2025 Next due 31 Mar 2027 11 months remaining
Confirmation Submitted 6 Mar 2026 Next due 8 Feb 2027 9 months remaining
Net assets £-7M £3M 2025 year on year
Total assets £2M £388K 2025 year on year
Total Liabilities £10M £4M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT England

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for CLOSED LOOP MEDICINE LTD (10584642), an active healthcare and wellbeing company based in Altrincham, England. Incorporated 26 Jan 2017. Research and experimental development on biotechnology. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type Total Exemption Full
Next accounts 31 December 2026
Due by 30 September 2027 9 months

Net Assets, Total Assets & Total Liabilities (2017–2025)

Cash in Bank

£1.89M

Increased by £1.01M (+115%)

Net Assets

-£7.01M

Decreased by £3.49M (-99%)

Total Liabilities

£9.50M

Increased by £3.88M (+69%)

Turnover

N/A

Employees

29

Decreased by 9 (-24%)

Debt Ratio

382%

Increased by 114 (+43%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
Dec Year End
2024
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 3

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

15 Allotments 99,802 Shares £21.35m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
4 Feb 202275£2k£22.4
30 Nov 2021337£89k£264.81
22 Oct 20219,487£2.01m£211.84
22 Oct 202145,166£11.96m£264.81
22 Oct 20214,701£1.38m£294.23

Officers

Officers

1 active 2 resigned
Status
Terlouw, Clare ElizabethDirectorBritish,canadianEngland522 Nov 2021Active

Shareholders

Shareholders (39)

Bgf Nominees Limited
21.4%
Longwall Ventures 3 Ecf (nominee) Limited
21.4%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased
Ceased

Paul Goldsmith

Ceased 4 Apr 2018

Ceased

Hakim Adam Yadi

Ceased 7 Jul 2017

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
30 Mar 2026CapitalAllotment of shares (GBP 151.509) on 2026-03-30
6 Mar 2026Confirmation StatementConfirmation statement made on 2026-01-25 with no updates
3 Dec 2025OfficersTermination of Paul David Johnson as director on 2025-11-30
26 Aug 2025AccountsAnnual accounts made up to 2025-06-30
20 Aug 2025AccountsAnnual accounts made up to 2025-12-31
30 Mar 2026 Capital

Allotment of shares (GBP 151.509) on 2026-03-30

6 Mar 2026 Confirmation Statement

Confirmation statement made on 2026-01-25 with no updates

3 Dec 2025 Officers

Termination of Paul David Johnson as director on 2025-11-30

26 Aug 2025 Accounts

Annual accounts made up to 2025-06-30

20 Aug 2025 Accounts

Annual accounts made up to 2025-12-31

Recent Activity

Latest Activity

Allotment of shares (GBP 151.509) on 2026-03-30

2 weeks ago on 30 Mar 2026

Confirmation statement made on 2026-01-25 with no updates

1 months ago on 6 Mar 2026

Termination of Paul David Johnson as director on 2025-11-30

4 months ago on 3 Dec 2025

Annual accounts made up to 2025-06-30

7 months ago on 26 Aug 2025

Annual accounts made up to 2025-12-31

8 months ago on 20 Aug 2025